Publications

Publications of Dr. Bagrodia

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors

Bagrodia A, Lee BH, Lee W, et al. J Clin Oncol. 2016;34(33):4000–4007. doi:10.1200/JCO.2016.68.7798

Serum MicroRNA-371a-3p Levels Predict Viable Germ Cell Tumor in Chemotherapy-naïve Patients Undergoing Retroperitoneal Lymph Node Dissection

Lafin JT, Singla N, Woldu SL, Lotan Y, Lewis CM, Majmudar K, Savelyeva A, Kapur P, Margulis V, Strand DW, Murray MJ, Amatruda JF, Bagrodia A. Eur Urol. 2020 Feb;77(2):290-292. doi: 10.1016/j.eururo.2019.10.005. Epub 2019 Nov 5. PMID: 31699528.

MicroRNAs: Turning the Tide in Testicular Cancer

Singla N, Lafin JT, Bagrodia A. Eur Urol. 2019 Nov;76(5):541-542. doi: 10.1016/j.eururo.2019.06.010. Epub 2019 Jun 21. PMID: 31230742.

Genetics of Testicular Germ Cell Tumors

Singla N, Lafin JT, Ghandour RA, Kaffenberger S, Amatruda JF, Bagrodia A. Curr Opin Urol. 2019 Jul;29(4):344-349. doi: 10.1097/MOU.0000000000000642. PMID: 31045925; PMCID: PMC6659740.

A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma

Leão R, Nayan M, Punjani N, Jewett MAS, Fadaak K, Garisto J, Lewin J, Atenafu EG, Sweet J, Anson-Cartwright L, Boström P, Chung P, Warde P, Bedard PL, Bagrodia A, Freifeld Y, Power N, Winquist E, Hamilton RJ. Eur Urol Focus. 2018 Dec;4(6):995-1001. doi: 10.1016/j.euf.2018.01.015. Epub 2018 Feb 7. PMID: 29428550.

Stereotactic Ablative Radiotherapy (SAbR) in the Setting of Metastatic Nonseminomatous Germ Cell Tumor of Testis

Satyanarayan A, Mooney R, Bhanvadia RR, Iyengar P, Margulis V, Desai NB, Bagrodia A. Clin Genitourin Cancer. 2019 Aug;17(4):e768-e771. doi: 10.1016/j.clgc.2019.04.005. Epub 2019 Apr 26. PMID: 31109801.

Site of Extranodal Metastasis Impacts Survival in Patients With Testicular Germ Cell Tumors

Patel HD, Singla N, Ghandour RA, Freifeld Y, Cheaib JG, Woldu SL, Pierorazio PM, Bagrodia A. Cancer. 2019 Nov 15;125(22):3947-3952. doi: 10.1002/cncr.32427. Epub 2019 Jul 29. PMID: 31355922; PMCID: PMC6819223.

Management of Stage II Germ Cell Tumors

Ghandour RA, Singla N, Bagrodia A. Urol Clin North Am. 2019 Aug;46(3):363-376. doi: 10.1016/j.ucl.2019.04.002. Epub 2019 May 15. PMID: 31277731.

Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes

Woldu SL, Moore JA, Ci B, Freifeld Y, Clinton TN, Aydin AM, Singla N, Laura-Maria K, Hutchinson RC, Amatruda JF, Sagalowsky A, Lotan Y, Arriaga Y, Margulis V, Xie Y, Bagrodia A. Eur Urol Oncol. 2018 Aug;1(3):242-251. doi: 10.1016/j.euo.2018.04.005. Epub 2018 Jun 6. PMID: 31058267; PMCID: PMC6494089.

Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses

Woldu SL, Aydin AM, Rao AV, Hutchinson RC, Singla N, Clinton TN, Krabbe LM, Passoni NM, Raj GV, Miller DS, Amatruda JF, Sagalowsky AI, Lotan Y, Arriaga Y, Margulis V, Bagrodia A. Urology. 2018 Feb;112:103-111. doi: 10.1016/j.urology.2017.08.059. Epub 2017 Dec 6. PMID: 29079210.

Nationwide Patterns of Care for Stage II Nonseminomatous Germ Cell Tumor of the Testicle

Ghandour R, Ashbrook C, Freifeld Y, Singla N, El-Asmar JM, Lotan Y, Margulis V, Eggener S, Woldu S, Bagrodia A. Eur Urol Oncol. 2019 Jul 1:S2588-9311(19)30082-3. doi: 10.1016/j.euo.2019.06.007. Epub ahead of print. PMID: 31272940.